BPC-157 has a remarkable safety profile compared to many therapeutic compounds
(15) found that the other cataract patients had lower levels of HbA1c, FPG, HOMA-IR, IGF-1, and IL-6 than the patients with diabetic cataracts
Increased Risk of Heart Attack or Stroke Although Wegovy is promoted for chronic weight management, some Wegovy users may face an increased risk of heart attack or stroke, especially those with underlying heart conditions
The program began covering GLP-1s for weight loss, but costs were significant enough that the state told providers this year that it is now focusing on other obesity treatments instead
Like Orforglipron, it also belongs to the GLP-1 receptor agonist class, meaning it works by helping control blood sugar, slowing digestion, and reducing appetite